CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez, I.
Right arrow Articles by Firestone, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez, I.
Right arrow Articles by Firestone, G. L.

Cell Growth & Differentiation, Vol 4, Issue 3 215-225, Copyright © 1993 by American Association of Cancer Research


ARTICLES

Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression

I Sanchez, L Goya, AK Vallerga and GL Firestone
Department of Molecular and Cell Biology, University of California, Berkeley 94720.

We have previously documented that glucocorticoids suppress the proliferation of BDS1 hepatoma cells, a rat epithelial tumor cell line derived from minimal deviation Reuber H35 hepatoma cells. Flow cytometry demonstrated that, after treatment with the synthetic glucocorticoid dexamethasone, the growth of an asynchronous population of BDS1 cells was arrested within one cell cycle which resulted in an accumulation of cells with a G1-G0-like DNA content. Consistent with a glucocorticoid-induced block early in the G1 phase of the cell cycle, propidium iodide flow cytometry revealed that addition of dexamethasone up to 2 h after release from contact inhibition prevented BDS1 hepatoma cells from entering S phase, whereas dexamethasone treatment after 2 h had no effect on the entry of cells into S phase. Moreover, dexamethasone treatment did not prevent BDS1 cells from entering S phase after release from synchronization at the G1-S boundary by a double thymidine block. Analysis of DNA content, [3H]-thymidine incorporation, and autoradiography of [3H]-thymidine-labeled nuclei revealed that, after release from dexamethasone, BDS1 cells synchronously reinitiated cell cycle progression and entered S phase 8 h after hormone withdrawal. Northern blot analysis demonstrated that the level of transcripts encoding the G1 marker genes CYL-1 and CYL-2 G1 cyclins peaked 4 h after dexamethasone withdrawal. Dexamethasone induced a 20-fold increase in the level of c-jun mRNA which was reversed after hormone withdrawal, whereas expression of c-fos transcripts remained at a low level during the time course of hormone treatment and withdrawal. Transient transfections with a collagenase-chloramphenicol acetyltransferase reporter gene showed that dexamethasone inhibited 12-O-tetradecanoylphorbol-13-acetate-inducible, but not basal, AP-1 transcription factor activity. Our results demonstrate that glucocorticoids reversibly induce an early G1 block in cell cycle progression of an epithelial tumor cell line that occurs with a coordinate elevation in the expression of c-jun transcripts.


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C. E. Perrone, D. A. L. Mattocks, G. Hristopoulos, J. D. Plummer, R. A. Krajcik, and N. Orentreich
Methionine restriction effects on 11 -HSD1 activity and lipogenic/lipolytic balance in F344 rat adipose tissue
J. Lipid Res., January 1, 2008; 49(1): 12 - 23.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Roca, R. M. Kypta, and M. d. M. Vivanco
Loss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development
PNAS, March 18, 2003; 100(6): 3113 - 3118.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. CROCHEMORE, T. M. MICHAELIDIS, D. FISCHER, J.-P. LOEFFLER, and O. F. X. ALMEIDA
Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation
FASEB J, June 1, 2002; 16(8): 761 - 770.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. H. RABBITT, G. G. LAVERY, E. A. WALKER, M. S. COOPER, P. M. STEWART, and M. HEWISON
Prereceptor regulation of glucocorticoid action by 11{beta}-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation
FASEB J, January 1, 2002; 16(1): 36 - 44.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sakai, T. Biwa, T. Matsumura, T. Takemura, H. Matsuda, Y. Anami, T. Sasahara, S. Kobori, and M. Shichiri
Glucocorticoid Inhibits Oxidized LDL-Induced Macrophage Growth by Suppressing the Expression of Granulocyte/Macrophage Colony-Stimulating Factor
Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1726 - 1733.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. A. Ramos, W. J. Meilandt, E. C. Wang, and G. L. Firestone
Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant
FASEB J, January 1, 1999; 13(1): 169 - 180.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
C. M. Cover, S. J. Hsieh, S. H. Tran, G. Hallden, G. S. Kim, L. F. Bjeldanes, and G. L. Firestone
Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling
J. Biol. Chem., February 13, 1998; 273(7): 3838 - 3847.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. H. Cha, E. J. Cram, E. C. Wang, A. J. Huang, H. G. Kasler, and G. L. Firestone
Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21waf1/cip1 Promoter in Rat Hepatoma Cells
J. Biol. Chem., January 23, 1998; 273(4): 1998 - 2007.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. J. Cram, R. A. Ramos, E. C. Wang, H. H. Cha, Y. Nishio, and G. L. Firestone
Role of the CCAAT/Enhancer Binding Protein-{alpha} Transcription Factor in the Glucocorticoid Stimulation of p21waf1/cip1 Gene Promoter Activity in Growth-arrested Rat Hepatoma Cells
J. Biol. Chem., January 23, 1998; 273(4): 2008 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. L. Crossin, M.-H. Tai, L. A. Krushel, V. P. Mauro, and G. M. Edelman
Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation
PNAS, March 18, 1997; 94(6): 2687 - 2692.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.